Medikament Lecanemab verlangsamt kognitiven Verfall bei Alzheimer-Demenz
Das zur Behandlung von Alzheimer-Demenz entwickelte Medikament Lecanemab soll laut einer Studie den kognitiven Verfall im Spätstadium um 27 ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.